Roger Ho
Professor and Senior Consultant Psychiatrist at the National University of Singapore and National University Hospital
Data updated
Research Footprint
Roger Ho appears in 10 tracked papers (2020–2024), most studied alongside Ketamine, Esketamine and Psilocybin, across Depressive Disorders, Major Depressive Disorder (MDD) and Treatment-Resistant Depression (TRD).
Most-cited paper: Synthesizing the Evidence for Ketamine and Esketamine in Treatment-Resistant Depression: An International Expert Opinion on the Available Evidence and Implementation (676 citations).
Frequent co-authors: Jonathan Rosenblat, Roger McIntyre and Joseph Vincenzo.
Publication Landscape
How the 10 papers Blossom tracks for Roger Ho line up by year, topic, and journal. These are the psychedelic-relevant papers in Blossom's records as of July 2026, not a complete bibliography.
How has Roger Ho's publishing grown?
SourcedTracked papers by publication year. Click a year for the running total.
Don't read as total output: only the 10 of 10 tracked papers with a recorded publication date are counted, and these are the psychedelic-relevant papers Blossom tracks, not a complete bibliography. The current year is still filling in.
What does Roger Ho publish on?
SourcedTracked papers per topic. Orange marks the largest research focus.
Don't read shares as adding to 100%: a paper tagged with several topics counts once per topic. These are the psychedelic-relevant papers Blossom tracks, not a complete bibliography.
Where does Roger Ho publish?
SourcedTracked papers per journal. Orange marks the most-used journal.
Counts the journal recorded on each tracked paper; preprints and papers with no journal on file are not shown. These are the psychedelic-relevant papers Blossom tracks, not a complete bibliography.
Background & Research
Roger Ho Chun Man is a psychiatrist and academic clinician based at the National University of Singapore (NUS) and National University Hospital (NUH). He serves as Professor and Senior Consultant Psychiatrist, and is also Research Director for the Department of Psychological Medicine and Director of the fNIRS Group at iHealthtech, NUS. His research interests include major depressive disorder, psychiatric diagnosis, and technology-enabled precision psychiatry, and he has published extensively in peer-reviewed journals.
Key Impact
He is a highly cited psychiatrist whose work spans depression, suicidality, ketamine/esketamine, and related psychiatric outcomes, making him relevant to both psychedelic and rapid-acting antidepressant research.
Collaboration Network
25 collaborators· click a node to visit their profile
Full network →Collaboration Network
See Roger Ho's full collaboration network, shared papers, and research connections.
Compounds
Topics
Top Collaborators
Top Collaborators
Unlock clinical summaries, full texts, and related trial mapping.
Affiliations
Institutions, companies, and organisations Roger Ho is associated with.